• Je něco špatně v tomto záznamu ?

Human cytochrome-P450 enzymes metabolize N-(2-methoxyphenyl)hydroxylamine, a metabolite of the carcinogens o-anisidine and o-nitroanisole, thereby dictating its genotoxicity

K. Naiman, M. Martínková, HH. Schmeiser, E. Frei, M. Stiborová,

. 2011 ; 726 (2) : 160-8. [pub] 20110918

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc12022490

N-(2-Methoxyphenyl)hydroxylamine is a component in the human metabolism of two industrial and environmental pollutants and bladder carcinogens, viz. 2-methoxyaniline (o-anisidine) and 2-methoxynitrobenzene (o-nitroanisole), and it is responsible for their genotoxicity. Besides its capability to form three deoxyguanosine adducts in DNA, N-(2-methoxyphenyl)-hydroxylamine is also further metabolized by hepatic microsomal enzymes. To investigate its metabolism by human hepatic microsomes and to identify the major microsomal enzymes involved in this process are the aims of this study. N-(2-Methoxyphenyl)hydroxylamine is metabolized by human hepatic microsomes predominantly to o-anisidine, one of the parent carcinogens from which N-(2-methoxyphenyl)hydroxylamine is formed, while o-aminophenol and two N-(2-methoxyphenyl)hydroxylamine metabolites, whose exact structures have not been identified as yet, are minor products. Selective inhibitors of microsomal CYPs, NADPH:CYP reductase and NADH:cytochrome-b(5) reductase were used to characterize human liver microsomal enzymes reducing N-(2-methoxyphenyl)hydroxylamine to o-anisidine. Based on these studies, we attribute the main activity for this metabolic step in human liver to CYP3A4, 2E1 and 2C (more than 90%). The enzymes CYP2D6 and 2A6 also partake in this N-(2-methoxyphenyl)hydroxylamine metabolism in human liver, but only to ∼6%. Among the human recombinant CYP enzymes tested in this study, human CYP2E1, followed by CYP3A4, 1A2, 2B6 and 2D6, were the most efficient enzymes metabolizing N-(2-methoxyphenyl)hydroxylamine to o-anisidine. The results found in this study indicate that genotoxicity of N-(2-methoxyphenyl)hydroxylamine is dictated by its spontaneous decomposition to nitrenium/carbenium ions generating DNA adducts, and by its susceptibility to metabolism by CYP enzymes.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12022490
003      
CZ-PrNML
005      
20120918112132.0
007      
ta
008      
120806e20110918ne f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.mrgentox.2011.09.010 $2 doi
035    __
$a (PubMed)21946300
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Naiman, Karel $u Department of Biochemistry, Charles University, Prague, Czech Republic.
245    10
$a Human cytochrome-P450 enzymes metabolize N-(2-methoxyphenyl)hydroxylamine, a metabolite of the carcinogens o-anisidine and o-nitroanisole, thereby dictating its genotoxicity / $c K. Naiman, M. Martínková, HH. Schmeiser, E. Frei, M. Stiborová,
520    9_
$a N-(2-Methoxyphenyl)hydroxylamine is a component in the human metabolism of two industrial and environmental pollutants and bladder carcinogens, viz. 2-methoxyaniline (o-anisidine) and 2-methoxynitrobenzene (o-nitroanisole), and it is responsible for their genotoxicity. Besides its capability to form three deoxyguanosine adducts in DNA, N-(2-methoxyphenyl)-hydroxylamine is also further metabolized by hepatic microsomal enzymes. To investigate its metabolism by human hepatic microsomes and to identify the major microsomal enzymes involved in this process are the aims of this study. N-(2-Methoxyphenyl)hydroxylamine is metabolized by human hepatic microsomes predominantly to o-anisidine, one of the parent carcinogens from which N-(2-methoxyphenyl)hydroxylamine is formed, while o-aminophenol and two N-(2-methoxyphenyl)hydroxylamine metabolites, whose exact structures have not been identified as yet, are minor products. Selective inhibitors of microsomal CYPs, NADPH:CYP reductase and NADH:cytochrome-b(5) reductase were used to characterize human liver microsomal enzymes reducing N-(2-methoxyphenyl)hydroxylamine to o-anisidine. Based on these studies, we attribute the main activity for this metabolic step in human liver to CYP3A4, 2E1 and 2C (more than 90%). The enzymes CYP2D6 and 2A6 also partake in this N-(2-methoxyphenyl)hydroxylamine metabolism in human liver, but only to ∼6%. Among the human recombinant CYP enzymes tested in this study, human CYP2E1, followed by CYP3A4, 1A2, 2B6 and 2D6, were the most efficient enzymes metabolizing N-(2-methoxyphenyl)hydroxylamine to o-anisidine. The results found in this study indicate that genotoxicity of N-(2-methoxyphenyl)hydroxylamine is dictated by its spontaneous decomposition to nitrenium/carbenium ions generating DNA adducts, and by its susceptibility to metabolism by CYP enzymes.
650    _2
$a aniliny $x metabolismus $7 D000814
650    _2
$a zvířata $7 D000818
650    _2
$a anisoly $x metabolismus $7 D000840
650    _2
$a karcinogeny $x metabolismus $7 D002273
650    _2
$a systém (enzymů) cytochromů P-450 $x metabolismus $7 D003577
650    _2
$a adukty DNA $x metabolismus $7 D018736
650    _2
$a látky znečišťující životní prostředí $x metabolismus $7 D004785
650    _2
$a lidé $7 D006801
650    _2
$a hydroxylaminy $x metabolismus $7 D006898
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a jaterní mikrozomy $x metabolismus $7 D008862
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
655    _2
$a časopisecké články $7 D016428
700    1_
$a Martínková, Markéta
700    1_
$a Schmeiser, Heinz H
700    1_
$a Frei, Eva
700    1_
$a Stiborová, Marie
773    0_
$w MED00003430 $t Mutation research $x 0027-5107 $g Roč. 726, č. 2 (20110918), s. 160-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21946300 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120806 $b ABA008
991    __
$a 20120918112313 $b ABA008
999    __
$a ok $b bmc $g 944403 $s 779787
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 726 $c 2 $d 160-8 $e 20110918 $i 0027-5107 $m Mutation research $n Mutat Res $x MED00003430
LZP    __
$a Pubmed-20120806/12/01

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...